Discover how a crucial experiment challenged the role of NF-κB in Parkinson's disease, forcing scientists to rethink brain inflammation mechanisms.
Understanding excessive daytime sleepiness and unintended sleep episodes in Parkinson's patients treated with dopaminergic agents
Exploring how cholecystokinin (CCK) polymorphisms influence Parkinson's disease psychosis differently across racial groups.